INCR

Intercure Ltd.

5.19 USD

Last updated Oct 7, 18:25 UTC

Yesterday HIGH

$5.32

Yesterday LOW

$5.32

52w HIGH

$8.45

52w LOW

$3.4

EPS

-1.06

PE

-4.92

Next Earnings

Oct 20, 2026

Overview News Government Trades Fundamentals

Intercure Ltd. stock is down -3.71% since 30 days ago. The next earnings date is Oct 20, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 October’s closed higher than September.

Benzinga Newsdesk

Tue Sep 8, 2026

InterCure Regains Nasdaq Compliance

InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) ("InterCure" or the "Company") announced today that it received written confirmation from the Listing Qualifications Department of The Nasdaq Stock Market LLC
Benzinga Newsdesk

Mon Aug 24, 2026

InterCure shares are trading higher after the company announced a final settlement with Israeli tax authorities, securing $77 million in compensation for indirect damages from the October 7 attacks and subsequent war.
Benzinga Newsdesk

Mon Aug 24, 2026

InterCure Announces Final Settlement With Israeli Tax Authorities, Compensation Fund For About $77M In Indirect War Damages
Benzinga Newsdesk

Wed Aug 19, 2026

InterCure Announces 1-For-5 Reverse Stock Split, Effective August 24
Benzinga Newsdesk

Mon Jun 22, 2026

InterCure shares are trading higher after the company announced a private placement of shares to its CEO and other shareholders worth up to $18.6 million.
Benzinga Newsdesk

Mon Jun 22, 2026

InterCure Enters Private Placement With Its CEO And Other Shareholders For Commitments Of ~$7.4M, With Option To Increase To ~$18.6M

InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), today announced that, further to the Company’s prior reports regarding growing demand in Germany and opportunities
Benzinga Newsdesk

Mon Jun 15, 2026

InterCure Reports Growing Demand In Germany And Evaluates Opportunities In Regulated U.S. Medical Cannabis Markets

First Tranche Closing (50%) of Botanico Transaction Expands International Platform with Exclusive Access to U.S. Genetics, Premium Brands and Advanced AI-Driven Technologies; Company Reports Growing Demand in Germany and

UMAC $21.79 USD

ABBV $272.77 USD

INFQ $11.61 USD

DRAM DRAM $60.30 USD

IREN $38.45 USD

MU $1,086.12 USD

PEP $123.80 USD

CLSK $11.56 USD